RT Journal Article
SR Electronic
T1 Erratum: <em>Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort</em>
JF Gut
JO Gut
FD BMJ Publishing Group Ltd and British Society of Gastroenterology
SP 2060
OP 2060
DO 10.1136/gutjnl-2016-312444corr1
VO 65
IS 12
YR 2016
UL http://gut.bmj.com/content/65/12/2060.abstract
AB